STEVE PAKOLA
CIK 1700659 · Chief Medical Officer · last filed 2026-08-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.32M
Companies
2
Total Filings
25
Lifetime Open-Market Net
-$1.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGNX | Chief Medical Officer | 205,541 | $11.28 | $2.32M | -$1.73M | 18 | 2026-08-04 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Chief Medical Officer | — | $33.00 | — | $0 | 1 | 2019-02-20 |
Recent Filings · Page 2 of 3
25 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | RGNX | Tax (F) | −18,247 | -$262.8K | EDGAR |
| 2025-04-04 | RGNX | Tax (F) | −5,263 | -$42.5K | EDGAR |
| 2025-01-06 | RGNX | Mixed | +50,402 | -$107.4K | EDGAR |
| 2024-08-05 | RGNX | Grant (A) | +58,386 | $0 | EDGAR |
| 2024-03-07 | RGNX | Mixed | — | -$78.7K | EDGAR |
| 2024-03-05 | RGNX | Notice (144) | −12,878 | -$275.1K | EDGAR |
| 2024-01-04 | RGNX | Mixed | +4,429 | -$486.2K | EDGAR |
| 2024-01-03 | RGNX | Notice (144) | −17,237 | -$316.1K | EDGAR |
| 2023-01-05 | RGNX | Mixed | +85,613 | -$111.2K | EDGAR |
| 2022-01-04 | RGNX | Mixed | +6,150 | -$91.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.